Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUSTO V Sex Differences Analysis
NCT00245648Phase 3Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2001
- Primary completion
- Oct 2007
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of abciximab in ST elevation myocardial infarction (STEMI), sponsored by NYU Langone Health. Started Jun 2001; status: completed.
02
Drugs
abciximab
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00245648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245648.